T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.06% |
| 2 | Financials | 16.98% |
| 3 | Consumer Discretionary | 15.13% |
| 4 | Technology | 13.74% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Erie Indemnity
ERIE
$13.4B
| $6.74M | ﹤0.01% |
59,959
+3
| +0% | +$319 |
|
|
DRE
1377
DELISTED
Duke Realty Corp.
DRE
| $6.66M | ﹤0.01% |
250,599
+13,465
| +6% | +$343K |
|
1378
Regenxbio
RGNX
$698M
| $6.58M | ﹤0.01% |
354,480
-172,047
| -33% | -$3.29M |
|
|
NVRO
1379
DELISTED
NEVRO CORP.
NVRO
| $6.42M | ﹤0.01% |
88,297
+25,620
| +41% | +$2.19M |
|
|
JMP
1380
DELISTED
JMP Group LLC
JMP
| $6.37M | ﹤0.01% |
1,037,112
| – | – |
|
1381
Teradata
TDC
$2.59B
| $6.35M | ﹤0.01% |
233,751
+330
| +0.1% | +$9.31K |
|
|
MXIM
1382
DELISTED
Maxim Integrated Products
MXIM
| $6.35M | ﹤0.01% |
164,567
+468
| +0.3% | +$18.4K |
|
1383
XPO
XPO
$24.7B
| $6.29M | ﹤0.01% |
421,276
| – | – |
|
1384
Middlesex Water
MSEX
$1.1B
| $6.27M | ﹤0.01% |
145,924
-3,206
| -2% | -$123K |
|
1385
OGE Energy
OGE
$9.8B
| $6.25M | ﹤0.01% |
186,935
-5,423
| -3% | -$171K |
|
|
ENTL
1386
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $6.21M | ﹤0.01% |
327,233
+1,000
| +0.3% | +$19.2K |
|
1387
AutoNation
AN
$6.92B
| $6.15M | ﹤0.01% |
126,501
| – | – |
|
1388
Genpact
G
$5.71B
| $6.15M | ﹤0.01% |
252,854
+9,609
| +4% | +$229K |
|
1389
Cohu
COHU
$2.75B
| $6.05M | ﹤0.01% |
434,992
-12,660
| -3% | -$154K |
|
|
ZLTQ
1390
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $6M | ﹤0.01% |
+137,777
| New | +$5.55M |
|
|
STAY
1391
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.93M | ﹤0.01% |
367,470
+747
| +0.2% | +$11.2K |
|
1392
Berkshire Hathaway Class A
BRK.A
$1.08T
| $5.86M | ﹤0.01% |
24
| – | – |
|
|
DISH
1393
DELISTED
DISH Network Corp.
DISH
| $5.83M | ﹤0.01% |
100,583
-53,340
| -35% | -$3.05M |
|
|
FBR
1394
DELISTED
Fibria Celulose Sa
FBR
| $5.83M | ﹤0.01% |
606,100
-191,100
| -24% | -$1.61M |
|
1395
Rocket Pharmaceuticals
RCKT
$364M
| $5.77M | ﹤0.01% |
236,445
+1,675
| +0.7% | +$47.8K |
|
|
ELGX
1396
DELISTED
Endologix Inc
ELGX
| $5.68M | ﹤0.01% |
99,310
-5,510
| -5% | -$505K |
|
1397
Sunrun
RUN
$2.42B
| $5.65M | ﹤0.01% |
1,063,314
-116,129
| -10% | -$643K |
|
1398
Petrobras Class A
PBR.A
$103B
| $5.63M | ﹤0.01% |
638,700
+92,500
| +17% | +$881K |
|
1399
Avis
CAR
$4.84B
| $5.61M | ﹤0.01% |
152,987
-210,005
| -58% | -$7.61M |
|
1400
ON Semiconductor
ON
$32B
| $5.57M | ﹤0.01% |
436,741
+5,406
| +1% | +$64.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.